Obsessive-Compulsive Disorder (OCD) Clinical Trials

Find Obsessive-Compulsive Disorder (OCD) Clinical Trials Near You

Effects and Neurophysiological Mechanisms of Digital Mindfulness-Based Therapy for Obsessive-Compulsive Disorder

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomized controlled trial aims to evaluate the effects of digital mindfulness-based therapy in people with obsessive-compulsive disorder and to explore its possible psychological and neurophysiological mechanisms. A total of 150 participants with a primary diagnosis of obsessive-compulsive disorder will be randomly assigned in a 1:1:1 ratio to one of three groups: digital mindfulness-based therapy, routine pharmacological treatment, or digital mindfulness-based therapy combined with routine pharmacological treatment. The digital mindfulness-based therapy program will last for 6 weeks and will be delivered through a mobile mini-program using structured video and audio lessons, guided mindfulness practices, supervised weekly learning, and home practice. Participants in the pharmacological treatment group will receive routine pharmacological treatment for obsessive-compulsive disorder, and participants in the combined group will receive both interventions. Changes in obsessive-compulsive symptoms, mindfulness, emotional symptoms, and other psychological outcomes will be assessed during treatment and follow-up. Heart rate variability will be assessed at baseline and weekly during the 6-week intervention. Electroencephalography will be assessed at baseline, at the end of the 6-week intervention, and at the 3-month and 6-month follow-up assessments to explore neurophysiological changes associated with treatment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Maximum Age: 65
Healthy Volunteers: f
View:

• A primary diagnosis of obsessive-compulsive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

• Aged 12 to 65 years.

• Primary school education or above and able to understand the study procedures and complete the required assessments.

• Willing and able to provide written informed consent. For participants under 18 years of age, written informed consent will also be obtained from a parent or legal guardian.

• Participants who are already receiving psychotropic medication must have maintained a stable medication regimen for at least 4 weeks before enrollment. Any clinically necessary medication changes during the study will be documented.

Locations
Other Locations
China
The Second Xiangya Hospital of Central South University
RECRUITING
Changsha
The Third Xiangya Hospital of Central South University
RECRUITING
Changsha
Contact Information
Primary
Chen Pan, Dr
758933968@qq.com
86-0731-88618487
Backup
Xuan Zhang
liekka1018@163.com
Time Frame
Start Date: 2026-07-15
Estimated Completion Date: 2028-10-31
Participants
Target number of participants: 150
Treatments
Experimental: Digital Mindfulness-Based Therapy
Participants assigned to this arm will receive a 6-week digital mindfulness-based therapy program delivered through a mobile mini-program. The intervention includes structured video and audio lessons, guided mindfulness practices, supervised weekly learning, and home practice.
Active_comparator: Routine Pharmacological Treatment
Participants assigned to this arm will receive routine pharmacological treatment for obsessive-compulsive disorder as determined by the treating psychiatrist.
Experimental: Digital Mindfulness-Based Therapy Plus Routine Pharmacological Treatment
Participants assigned to this arm will receive both the 6-week digital mindfulness-based therapy program and routine pharmacological treatment for obsessive-compulsive disorder.
Related Therapeutic Areas
Sponsors
Leads: Central South University
Collaborators: Second Xiangya Hospital of Central South University

This content was sourced from clinicaltrials.gov